Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol
Authors:
- Sergio RutellaSRSergio Rutella
- Paola IudiconePIPaola Iudicone
- Giuseppina BonannoGBGiuseppina Bonanno
- Daniela FioravantiDFDaniela Fioravanti
- Annabella ProcoliAPAnnabella Procoli
- Claudio LavorinoCLClaudio Lavorino
- Maria Laura FoddaiMFMaria Laura Foddai
- Domenica LorussoDomenica Lorusso
- Enrica MartinelliEMEnrica Martinelli
- Michele VaccaMVMichele Vacca
- Francesco IpsevichFIFrancesco Ipsevich
- Marianna NutiMNMarianna Nuti
- 1 August 2012
- journal article
- Published by Elsevier in Cytotherapy
- Vol. 14 (7) , 841-850
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2011
- Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicityBlood, 2011
- Revisiting human natural killer cell subset function revealed cytolytic CD56 dim CD16 + NK cells as rapid producers of abundant IFN-γ on activationProceedings of the National Academy of Sciences, 2010
- Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade culturesJournal of Translational Medicine, 2010
- Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)Journal of Cancer Research and Clinical Oncology, 2010
- Interleukin-21 induces the differentiation of human umbilical cord blood CD34-lineage- cells into pseudomature lytic NK cellsBMC Immunology, 2009
- Rabbit Antithymocyte Globulin (Thymoglobulin®)Drugs, 2009
- Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trialHematological Oncology, 2009
- Comparative study of four fluorescent probes for evaluation of natural killer cell cytotoxicity assaysImmunobiology, 2008
- Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activationNature, 2002